Search filters

List of works by Antonio Passaro

Acquired Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers: The Role of Next-Generation Sequencing on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples.

scientific article published in April 2018

Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations

scientific article published on 20 November 2018

Afatinib as first-line treatment for patients with advanced non-small-cell lung cancer harboring EGFR mutations: focus on LUX-Lung 3 and LUX-Lung 6 phase III trials.

scientific article published on August 2013

Afatinib for the first-line treatment of patients with metastatic EGFR-positive NSCLC: a look at the data.

scientific article

Afatinib in EGFR TKI-naïve patients (pts) with locally advanced/metastatic NSCLC harbouring EGFR mutations: An interim analysis of a phase IIIB trial

scientific article published on 01 April 2019

Afatinib in NSCLC harbouring EGFR mutations

scientific article published on 01 April 2014

Afatinib in first-line setting for NSCLC harbouring common EGFR mutations: new light after the preliminary results of LUX-Lung 7?

scientific article

Afatinib-related nonhematologic adverse events: is common evaluation enough for now?

scientific article published on 03 February 2014

Biopsy and re-biopsy in lung cancer: the oncologist requests and the role of endobronchial ultrasounds transbronchial needle aspiration

scientific article

Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies

scientific article

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

scientific article published on 21 November 2019

Brigatinib for the treatment of ALK-positive advanced non-small cell lung cancer patients.

scientific article published in August 2017

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

scientific article

Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment

scientific article published on 01 December 2019

Clinical and treatment features associated with improved 5-year survival rate in ALK-positive lung cancer treated with ALK-TKIs

scientific article published on 01 April 2019

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.

scientific article

Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?

scientific article published on 19 September 2017

Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells.

scientific article published on 20 January 2018

Concomitant ALK translocation and other non-EGFR gene in NSCLC: knowledge in the making.

scientific article

Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy

scientific article published on 01 April 2020

Correlation among different KRAS alterations, genetic co-mutations and PD-L1 expression in patients treated with immunotherapy in metastatic NSCLC

scientific article published on 01 April 2019

Dacomitinib in EGFR-positive non-small cell lung cancer: an attractive but broken option.

scientific article

Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

scientific article published on 25 January 2020

Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer.

scientific article

EGFR-TKIs in non-small-cell lung cancer: focus on clinical pharmacology and mechanisms of resistance

scientific article published on 22 May 2018

ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer

scientific article published on 01 June 2020

Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective Analysis

scientific article published on 01 January 2020

Ensartinib (X-396) a novel drug for anaplastic lymphoma kinase-positive non-small cell lung cancer patients: we need smart trials to avoid wasting good bullets

scientific article published on 15 October 2018

Erlotinib and gefitinib for elderly patients with advanced non-small-cell lung cancer

scientific article published on June 2014

European Society for Medical Oncology (ESMO) 2018 Congress Twitter analysis: from ethics to results through the understanding of communication and interaction flows

scientific article published on 05 February 2020

First-line treatment in NSCLC harboring EGFR common mutations: EGFR TKI in monotherapy or in combination with anti-VEGF?

scientific article

Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM)

article

Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy

scientific article published on 28 June 2019

Immunotherapy in Non-Small-Cell Lung Cancer Patients With Performance Status 2: Clinical Decision Making With Scant Evidence

scientific article published on 17 April 2019

Immunotherapy in refractory SCLC: the caterpillar struggling to become a butterfly

scientific article published on 01 November 2018

Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings

scientific article published on 11 October 2019

Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.

scientific article published on 16 November 2015

Lung Tissue Injury as an Atypical Response to Nivolumab in Non-Small Cell Lung Cancer.

scientific article

Molecular and Clinical Analysis of Predictive Biomarkers in Non-Small-Cell Lung Cancer ⬇️

scientific article published on January 1, 2012

Multimodality treatment of gynecomastia in patients receiving antiandrogen therapy for prostate cancer in the era of abiraterone acetate and new antiandrogen molecules.

scientific article

Neoadjuvant EGFR TKIs: toward personalized management in non-small-cell lung cancer.

scientific article

Nivolumab in second-line treatment of squamous non-small cell lung cancer

scientific article

Overcoming resistance to osimertinib in non-small cell lung cancer: Hopes, doubts, and in-between

scientific article published on 10 March 2020

Prognostic value of lymph node ratio in patients with pathological N1 non-small cell lung cancer: a systematic review with meta-analysis

scientific article published on June 2016

Proposals for revisions of the classification of lung cancers with multiple pulmonary sites: the radiologist's, thoracic surgeon's and oncologist's point of view

scientific article published on August 2016

Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer

scientific article published on 28 October 2019

Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors? ⬇️

scientific article published on October 1, 2011

Sensitive and affordable diagnostic assay for the quantitative detection of anaplastic lymphoma kinase (ALK) alterations in patients with non-small cell lung cancer.

scientific article published on 19 May 2016

Setting the Benchmark for <i>KRAS<sup>G12C</sup></i>-Mutated NSCLC

scientific article published in 2022

Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment.

scientific article

The Impact of Chemotherapy on the Lymphatic System in Thoracic Oncology ⬇️

scientific article published on December 29, 2011

The immune profile of EGFR-mutated non-small-cell lung cancer at disease onset and progression after tyrosine kinase inhibitors therapy

scientific article published on 01 September 2018

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

scientific article published on 28 December 2019

Understanding EGFR heterogeneity in lung cancer

scientific article published on 01 October 2020

Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy

scientific article published on 14 August 2019

Vitamin supplementation in patients receiving pemetrexed for advanced non-small cell lung cancer.

scientific article

erbB in NSCLC as a molecular target: current evidences and future directions

scientific article published on 01 August 2020

management of nonhematologic toxicities associated with different EGFR-TKIs in advanced NSCLC: a comparison analysis.

scientific article

Paulina is supported by:

About Paulina

Help